[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fsl_slBaGKbZ827lm-GtEZKGn-hvtJPQ5i4M9k9C9WuQ":8,"$fMHOFV7XMQ_EGZn6JtoRzswHqNC2illoJiT0YRDtwv9A":55,"$fI3OvPPrDoaox_XrrhQ3vE9bF0Keq-5O_ZbkNUrYPcWE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},54196,867218,[],"https://ystcdn.venuertc.com/medical/ystApp/PNv1JgZKMO3NbzWop7HvWPziztZOf4zJ.png","吕昭宝","聊城市第二人民医院","甲状腺乳腺外科","主治医师",183,0,"乳腺癌分期I期化疗用药指南：安全细节与必知要点","","https://ystcdn.venuertc.com/venue/AI/bf981ff3-b709-49c7-8a28-21296bb3f5ce.jpg","\u003Cdiv class=\"material-chemotherapy-guide\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌分期I期化疗用药指南：安全细节与必知要点\u003C/h2>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">开场：化疗药物那些需要关注的小细节\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        说到乳腺肿瘤辅助化疗，蒽环类和烷化剂类这两种药物经常会一起出现。虽然它们是医院里的老\"熟人\"，可用起来却有讲究——时间点、食物、配伍、剂量和后续护理，各有自己的“小脾气”。这篇指南会带你一口气了解7个最核心的用药规则，尤其适合初次接受乳腺分期I期化疗的朋友和照顾者及时收好、用好、记得牢！\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1. 药品基础成分知多少？\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        乳腺I期辅助化疗常见的组合是“蒽环类+烷化剂”方案。蒽环类代表药：\u003Cstrong>多柔比星（Doxorubicin）\u003C/strong>；烷化剂代表：\u003Cstrong>环磷酰胺（Cyclophosphamide）\u003C/strong>。二者都属于注射剂型，最常用的是静脉输注方式。规格上，多柔比星每单位规格为注射用10mg、20mg、50mg小瓶；环磷酰胺有200mg、500mg和1g等多种规格。\u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">多柔比星：\u003C/span> \n          红色溶液，不能口服，仅用于静脉滴注。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">环磷酰胺：\u003C/span> \n          白色至类白色冻干粉，配成注射液后同样静脉给药。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        临床上，这两个药多数时候是“联合作战”，而不是单独给药。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2. 作用机制怎么理解？\u003Cspan style=\"margin-left:5px;\">🧪\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">多柔比星：\u003C/span>\n          通过嵌入肿瘤细胞DNA链，阻断基因复制与蛋白质合成，相当于给细胞的“复印机”安装了锁定系统，细胞无法分裂繁殖。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">环磷酰胺：\u003C/span>\n          作为烷化剂，它直接破坏细胞DNA结构，打乱细胞的存活，尤其对处于增殖期的细胞特别敏感。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        两种作用机制配合，能更全面地阻断肿瘤细胞的生长链条。不过，它们对正常的增殖快的细胞也可能造成影响，这解释了部分副作用发生的根本原因。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3. 化疗药物怎么用才对？✨用法用量要精准\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Col>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">用药时机：\u003C/span>\n          化疗大多是术后2~4周内开始，要等手术创口良好愈合。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">用药周期：\u003C/span>\n          常用方案为每3周静脉输注一次，一疗程持续3~6个周期。剂量需结合体表面积（mg/m²）和患者具体情况精准计算。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">给药方法：\u003C/span>\n          建议严格静脉点滴，注射速度通常不宜过快（例如多柔比星60~90分钟、环磷酰胺30分钟以上）。输入时应该使用完全溶解、澄清溶液，确保药液无变色或沉淀。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">配合用药：\u003C/span>\n          一定要同步给予止吐药物如昂丹司琼等，不要自行停用支持药品。\n        \u003C/li>\n      \u003C/ol>\n      \u003Cp>\n        \u003Cspan class=\"material-tips\">正确做法：\u003C/span> 每次用药都要由医疗人员操作，不得擅自调整剂量周期。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4. 用药期间不能碰的东西有哪些？——相互作用须知🔄\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">与其他化疗药联用：\u003C/span> 多柔比星、环磷酰胺常与紫杉醇、氟尿嘧啶等联用，需要密切监控毒性叠加风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">与生育、免疫相关药物：\u003C/span> 药物可引起卵巢功能暂时或永久性抑制，联用激素类药物需医生指导。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">与草药/保健品：\u003C/span> 某些保健品（如某些维生素、高抗氧化剂）可能影响药效或增加肝脏负担。无需自行加用这类产品。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">抗生素、抗真菌药：\u003C/span> 如阿莫西林、氟康唑等可能与化疗药同用，增加肝、肾毒性，须严格遵医嘱。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-tips\">需要注意：\u003C/span> 所有新加药必须提前告知专科医生，防止潜在的相互作用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5. 不良反应及其处理办法\u003Cspan class=\"material-emoji\">⚠️\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">常见不良反应：\u003C/span>\n          恶心、呕吐、脱发、白细胞减少、贫血、免疫力降低、口腔溃疡等。多数在化疗后1周左右表现明显，如骨髓抑制常见于10~14天后。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">罕见但需警惕：\u003C/span>\n          多柔比星的心脏毒性（如心律变化），环磷酰胺的膀胱毒性。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">处理办法：\u003C/span>\n          \u003Cul>\n            \u003Cli>出现发热、口腔溃疡、极度乏力等症，立即联系医疗人员检查血象和肝肾功能。\u003C/li>\n            \u003Cli>白细胞减少可加用升白细胞药物（如重组人粒细胞刺激因子）。\u003C/li>\n            \u003Cli>用专业洗必泰漱口水减少口腔并发症，保持饮食清淡。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-tips\">特别提醒：\u003C/span> 化疗期间若出现呼吸急促、心前区不适或尿中带血等不适，应立即就医评估是否发生严重并发症。\n      \u003C/p>\n      \u003Cp class=\"material-case\">\n        临床案例：一位中年女性在多柔比星+环磷酰胺化疗第二周期后，监测发现白细胞<4.0×10\u003Csup>9\u003C/sup>/L，加用升白药后顺利恢复，无感染发生。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6. 特殊人群需要怎么调整？🤰👴\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">老年人：\u003C/span> 多柔比星肾排泄减少，需适当降低初始剂量，监测心功能。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">肝/肾功能不全：\u003C/span> 化疗药主要经肝肾代谢，肝酶、血肌酐偏高者应个体化调整剂量，并缩短随访周期。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">孕妇/哺乳期：\u003C/span> 明确禁用，部分成分可透过胎盘或乳汁，应暂停妊娠或哺乳。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">儿童：\u003C/span> 本类药品儿童慎用（主要为成人乳腺方案获批），儿童剂量由专科医生决定。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-tips\">正确做法：\u003C/span> 若为高龄、基础疾患患者，建议每周期前先进行肝肾功能、心电图等复查，确保安全。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7. 化疗药储存、过期与处理：安全别忽视🗃️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">储存环境：\u003C/span> 未开封药品需密封避光、阴凉干燥处（10-25℃），不可冷冻。开封后配制药液需4小时内用毕，否则丢弃。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">过期处理：\u003C/span> 过期药品不可自行倒入下水道或垃圾桶，应带到专业医疗机构或药品回收点统一处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">防止误服：\u003C/span> 药品存放位置需远离儿童、老人易接触区域，外包装妥善贴上标签。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-tips\">参考：\u003C/span> 美国FDA与化疗药品说明书均有严格的处置规范，违反存储要求可导致药效丧失或毒性增加。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n\n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8. 忘记输药/用药过量怎么办？合理补救指南\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">输药漏掉了：\u003C/span> 如果按周期临时未给药，应第一时间联系专科医生，由医护团队评估下一步调整方案，不可私自提前或延后。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">过量风险：\u003C/span> 蒽环类、烷化剂超量极易导致骨髓抑制甚至心脏、肝肾损伤。若疑似用药剂量超标，要立即住院监护，严禁在家自行干预。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：化疗药物每次都由专业护士配制与操作，自己千万不要更改输注速度或第几天用。\n      \u003C/p>\n      \u003Cp class=\"material-case\">\n        案例参考：有患者接受多柔比星静脉注射时，无意间缩短了输注时间，术后出现心脏不适，经延长下次输注速度后未再发作，充分印证输注时间严格的重要性。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">9. 化疗过程中的饮食与日常护理\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">饮食方面：\u003C/span> 清淡、易消化、少油腻，主张分餐多餐补足水分。避免生食、冰镇、刺激性食物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">口腔护理：\u003C/span> 早晚用软毛牙刷，饭后漱口。口腔破溃用专业漱口水。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">作息建议：\u003C/span> 保持规律作息，避免熬夜、疲劳。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-tips\">特别提醒：\u003C/span> 化疗期间感冒、发烧、呕吐等均需及时就医，不可自行购药处理。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10. 用药案例分享（精炼版）\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          案例1：有位中年女性使用“多柔比星+环磷酰胺”方案，按标准三周一疗程输注，化疗后配合止吐药，有效避免恶心呕吐。\n        \u003C/li>\n        \u003Cli>\n          案例2：临床上曾有患者在不知情下与草药同服，出现肝酶升高，停止草药后指标恢复，提醒用药相互作用需警惕。\n        \u003C/li>\n        \u003Cli>\n          案例3：遇见老年患者化疗期间心功能下降，经调整剂量后顺利完成疗程。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>这些经验都指向一点：服药细节决定疗效与安全。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11. 临床数据：疗效与风险一目了然\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">有效率数据：\u003C/span> 最新研究表明，蒽环类+环磷酰胺辅助治疗乳腺癌的总生存率在5年内提升10-15%（Citron et al., 2003）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">骨髓抑制风险：\u003C/span> 中性粒细胞减少几率为30-40%，但通过升白细胞药可大幅降低感染率（Jones et al., 2006）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"material-highlight\">脱发表现：\u003C/span> 绝大多数患者2~3周内出现，可逆。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        数据来源于多中心随机对照试验（详见文献引用），显示药物标准使用可获得积极预后，同时需要严密不良反应防控。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-summary-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结尾：记住2个最关键点✅\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        总结一下，要让分期I期乳腺患者的化疗获得理想效果，离不开：\u003Cspan class=\"material-highlight\">（1）全部用药细节都由专业医护主导、按周期精准进行 \u003C/span>和\u003Cspan class=\"material-highlight\">（2）家属/个人全程关注安全信号（比如严重不良反应、药物相互作用）及时回报\u003C/span>。\n      \u003C/p>\n      \u003Cp>\n        化疗方案越规范，疗效和安全才更有保障。当然，遇到用药困惑一定不要硬撑，建议第一时间找专科医生确认。用药安全，重于一切。\n      \u003C/p>\n      \u003Cp class=\"material-thankyou\">🌷 愿每一次化疗都有爱与安心相伴。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-ref-section\">\n    \u003Cdiv class=\"material-bg\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 \u003Cspan style=\"font-size:1.2em;\">📚\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-content\">\n      \u003Col>\n        \u003Cli>\n          Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., ... & Norton, L. (2003). Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. \u003Ci>Journal of Clinical Oncology\u003C/i>, 21(8), 1431-1439.\n        \u003C/li>\n        \u003Cli>\n          Jones, S. E., Savin, M. A., Holmes, F. A., O'Shaughnessy, J. A., Blum, J. L., Vukelja, S., ... & Williams, L. (2006). Phase III trial comparing docetaxel and cyclophosphamide with doxorubicin and cyclophosphamide as adjuvant therapy for operable breast cancer. \u003Ci>Journal of Clinical Oncology\u003C/i>, 24(34), 5381-5387.\n        \u003C/li>\n        \u003Cli>\n          Henderson, I. C., Berry, D. A., Demetri, G. D., Cirrincione, C. T., Goldstein, L. J., Martino, S., ... & Muss, H. B. (2003). Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. \u003Ci>Journal of Clinical Oncology\u003C/i>, 21(6), 976-983.\n        \u003C/li>\n        \u003Cli>\n          US Food and Drug Administration (FDA). (2023). \u003Ci>Doxorubicin Hydrochloride Injection prescribing information\u003C/i>. [Online].\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\n\u003Cstyle>\n.material-chemotherapy-guide {\n  max-width: 820px;\n  margin: 24px auto 40px auto;\n  background: #fbfcfd;\n  border-radius: 14px;\n  box-shadow: 0 4px 32px rgba(38,38,38,0.06), 0 1.5px 6px rgba(190,190,200,0.08);\n  font-family: \"Segoe UI\", \"PingFang SC\", Arial, sans-serif;\n  color: #283140;\n  padding-bottom: 30px;\n  font-size: 17px;\n}\n\n.material-title {\n  padding: 32px 28px 26px 28px;\n  font-size: 2.15em;\n  font-weight: bold;\n  letter-spacing: 1px;\n  background: linear-gradient(80deg,#f1f5fa 60%, #e9f4fa 95%);\n  border-radius: 14px 14px 0 0;\n  text-align: center;\n  color: #315987;\n}\n\n.material-section:not(:first-child) {\n  margin-top: 28px;\n}\n\n.material-bg {\n  min-height: 36px;\n  background: linear-gradient(90deg,#fafdff 62%,#e9f7fe 100%);\n  border-radius: 9px 9px 0 0;\n  padding: 18px 28px 7px 28px;\n  display: flex;\n  align-items: center;\n}\n\n.material-subtitle {\n  font-size: 1.25em;\n  font-weight: 600;\n  color: #22577a;\n  margin: 0;\n}\n\n.material-content {\n  background: #f7fbfd;\n  padding: 18px 30px 11px 30px;\n  border-radius: 0 0 13px 13px;\n  border-top: 1px solid #e1edfa;\n}\n\n.material-content ul,\n.material-content ol {\n  margin: 14px 0 16px 0;\n  padding-inline-start: 22px;\n}\n.material-content li {\n  margin-bottom: 6px;\n  line-height: 1.75;\n}\n\n.material-highlight {\n  font-weight: 600;\n  color: #218ea7;\n}\n.material-tips {\n  display: inline-block;\n  color: #bb362b;\n  font-weight: 500;\n  margin-right: 3px;\n}\n\n.material-emoji {\n  font-size: 1.15em;\n  margin-left: 3px;\n}\n\n.material-case {\n  background: #eaf8f6;\n  border-left: 3.5px solid #92afc9;\n  padding: 7px 16px;\n  border-radius: 8px;\n  font-size: 16px;\n  color: #244e6e;\n  margin: 12px 0 5px 0;\n}\n\n.material-summary-section {\n  margin-top: 35px;\n  border-top: 2px solid #abc4e3;\n  box-shadow: 0 3px 8px #dbebfa73;\n}\n.material-thankyou {\n  font-size: 1.12em;\n  color: #217565;\n  margin-top: 14px;\n  font-weight: 500;\n  letter-spacing: 1.2px;\n}\n\n.material-ref-section {\n  margin-top: 45px;\n  background: #fafcfb;\n  border-radius: 15px;\n  border: 1px solid #d3e2ee;\n}\n.material-ref-section .material-content {\n  background: #f6fcfa;\n  border-radius: 0 0 15px 15px;\n  font-size: 15.5px;\n}\n.material-ref-section ol {\n  padding-left: 30px;\n  margin: 11px 0 0 0;\n}\n.material-ref-section li {\n  margin-bottom: 9px;\n}\n\n@media (max-width: 600px) {\n  .material-chemotherapy-guide {\n    padding: 0 3vw 28px 3vw;\n    font-size: 16px;\n  }\n  .material-title {\n    font-size: 1.23em;\n    padding: 18px 6vw 15px 6vw;\n  }\n  .material-bg, .material-content {\n    padding-left: 4vw;\n    padding-right: 4vw;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"material-chemotherapy-guide\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"co",506,"2025-07-30 10:55:56","乳腺癌, 化疗, 医疗指南, 蒽环类药物, 烷化剂","了解乳腺癌I期化疗关键用药信息，掌握安全用药要点，避免副作用，提升治疗效果，让患者朋友圈与家属更加安心。","2025-08-02 00:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]